Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Obesity 1Metabolic Syndrome 1Hyperandrogenism 1Cardiovascular Diseases 1

Interventions

Nutrition Assessment 3Exercise 3Blood Pressure 3Methods 2Ethanol 2Educational Status 2Diet, Mediterranean 2beta Carotene 1Vitamin E 1Standard of Care 1Spironolactone 1Simvastatin 1Rosuvastatin Calcium 1Restraint, Physical 1Resistance Training 1Referral and Consultation 1Quality of Life 1Pravastatin 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Physical Conditioning, Human 1Patient Navigation 1Nutritional Status 1Metformin 1Melatonin 1Lysine Acetyltransferase 5 1Jogging 1Interviews as Topic 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1High-Intensity Interval Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cardiovascular Diseases × Spironolactone × Clear all
NCT00842140 2010-07-22

Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women

University of Sao Paulo

Phase NA Completed
75 enrolled

Cardiovascular Diseases, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡